home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Peptides Congress 2014

 
  October 03, 2013  
     
 
Oxford Global, Novotel London West, One Shortlands, London, W6 8DR
3rd & 4th April 2014


Over 400 attendees working within Proteins, Antibodies, Peptides and Biotherapeutics

Over 20 case studies, presentations and panel discussions

Co-Located with our 7th Annual Proteins Congress

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Oxford Global Conferences are proud to present the Peptides Congress taking place on the 3rd & 4th April, 2014 at the Novotel London West, UK. Our esteemed experts will explore recent developments in peptide research from discovery and synthesis through to optimal engineering techniques and therapeutic applications.

The popularity of peptide therapeutics has increased significantly in recent years; the number of new peptides entering the clinic has doubled, and peptide therapies in the US have achieved sales over $1 billion. The Peptides Congress will bring together key decision makers and researchers in this revitalised field. On Day One, the Congress will examine various peptide discovery and synthesis techniques, whilst looking in detail at the design and production of peptide libraries and arrays, as well as synthesised and modified peptides. Our internationally renowned speakers will also give a detailed insight into protein-protein interactions and the production of bioactive peptides.

Due to their compelling potential, many major pharmaceuticals are seeing a resurgence of peptide use in their pipelines. The therapeutic potential of peptides is being embraced by the industry, and offers many novel opportunities for drug discovery. Day Two of the Congress will see discussions focus on peptide engineering, including peptidomimetics and peptide conjugation, as well as cell-penetrating peptides for molecular imaging. Additionally, our experts will discuss the potential of antimicrobial peptides in immunotherapy and as protease inhibitors in drug discovery.

The Peptides Congress is part of the highly successful Oxford Global Proteins Series.
 
 
Organized by: Oxford Global
Invited Speakers:

Maria A Bednarek
Principal Scientist and Head of Peptide Chemistry, MedImmune

·  Andrew A Young
VP and Head, Enteroendocrine Biology, GlaxoSmithKline

·  Fernando Albericio
General Director, Barcelona Science Park, Professor, University of Barcelona, Group Leader, Barcelona Biomedical Research Institute

·  Chantal Alcouffe
Medicinal Chemist Group Leader, Sanofi

·  Brian Austin
Professor of Protein Science, St George’s University of London

·  Christophe Bonny
CSO, Bicycle Therapeutics

·  Anna Collen
Director Reagent and Assay Development, AstraZeneca

·  Filip Cuyckens
Principal Scientist - Head of Analytical Sciences, Janssen

·  Darryl Davis
Principal Research Scientist, Janssen Pharmaceutical R&D

·  Stefan Geschwindner
Principal Scientist Biophysics & iCoach , AstraZeneca R&D

 
Deadline for Abstracts: NA
 
Registration: For more information or to book a place please visit; http://www.peptides-congress.com/download-agenda-marketing or contact r.mcivor@oxfordglobal.co.uk
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.